Genetic markers may predict disease behavior in patients with ulcerative colitis

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Previous research suggested HLA DRB1*0103 and IL-1RA allele 2 as predictors for severe and extensive ulcerative colitis.
• This study aimed to validate these genetic associations in a surgical ulcerative colitis cohort.

Purpose of the Study:

• To investigate the predictive value of HLA DRB1*0103 and IL-1RA allele 2 in patients with ulcerative colitis undergoing surgery.
• To explore associations between genetic markers, disease phenotype, and antineutrophil cytoplasmic antibody (ANCA) status.

Main Methods:

• HLA DRB1 and DQB1 genotyping in 99 patients and 472 controls.
• Genotyping for tumor necrosis factor alpha and IL-1RA polymorphisms in 107 patients and 89 controls.
• ANCA measurement in 72 patients and 58 healthy subjects using ELISA and immunofluorescence.

Main Results:

• The HLA DRB1*0103 allele was significantly increased in patients, particularly those with extensive disease or extraintestinal manifestations (P < 1 x 10[-5]).
• IL-1RA allele 2 frequency differed between extensive and distal colitis (P = 0.01).
• ANCA was detected in 76.4% of patients, with IL-1RA allele 2 and TNF2 allele carriage increased in ANCA-positive individuals.

Conclusions:

• Genetic markers, including HLA DRB1*0103 and IL-1RA allele 2, show potential for predicting disease behavior in ulcerative colitis.
• These findings support the role of specific genetic profiles in determining ulcerative colitis phenotype and progression.